Press releases
- Catalent, Inc. Investor Warning: 4/25/2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser
- CATALENT, INC. INVESTORS: April 25, 2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser
- Catalent, Inc. to Present at March Investor Conferences
- Catalent Appoints Sridhar Krishnan to Lead New Global Operational Excellence Strategy, “The Catalent Way”
- Catalent Publishes Fourth Annual Corporate Responsibility Report Highlighting Achievements While Providing New Record Number of Patient Treatments
- Catalent Appoints Joseph A. Ferraro as Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary
- Catalent, Inc. Reports Second Quarter Fiscal 2023 Results
- Catalent, Inc. Announces Second Quarter Fiscal Year 2023 Earnings Conference Webcast
- Catalent Appoints Ricardo Zayas as North American Biologics Operations Leader
- Sarepta and Catalent Expand Strategic Manufacturing Partnership With Commercial Supply Agreement for Duchenne Muscular Dystrophy Gene Therapy Candidate
More ▼
Key statistics
As of last trade, Catalent Inc (0C8:MUN) traded at 58.15, 45.63% above the 52 week low of 39.93 set on Nov 28, 2022.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 58.15 |
---|---|
High | 58.15 |
Low | 58.15 |
Bid | 59.61 |
Offer | 59.82 |
Previous close | 59.66 |
Average volume | 55.60 |
---|---|
Shares outstanding | 180.09m |
Free float | 179.31m |
P/E (TTM) | 28.61 |
Market cap | 11.64bn USD |
EPS (TTM) | 2.26 USD |
Data delayed at least 15 minutes, as of Mar 24 2023 07:00 BST.
More ▼